1,900 ARS
12.23 T ARS
38.41 T ARS
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
ISIN
ARDEUT110608
FIGI
BBG000HDMMT8
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
10%
30%
50%
70%
90%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
3.00 T
6.00 T
9.00 T
12.00 T
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
3.00 T
6.00 T
9.00 T
12.00 T
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
3.00 T
6.00 T
9.00 T
12.00 T
No news here
Looks like there's nothing to report right now
ABT long at 126.75 -- bad new is good news (for me)ABT got some bad news today when a Missouri judge ruled there would be a retrlal regarding a court case involving ABT's baby formula, and the stock, which was already down 3 days in a row, got thumped. While I don't dismiss long term risk from that news, I'm not in this for the long haul. I will l
$ABT : Reversal Pattern Just Dropped – Is $115 the NextAlright, let’s check out ABT on the daily chart. The stock enjoyed a steady climb since Jan 2025, riding a clear uptrend line, and now just nailed a technical reversal pattern, and it seems like it’s aiming for a target around $115 per share in the short term (1-3 months).
Abbott Laboratories | ABT | Long at $110.00Abbott Laboratories NYSE:ABT has been making higher highs and lower lows over the last year, potentially signaling a reversal in its downward trend. Monkeypox and the return of cold/flu/COVID season may spark another run to close the price gap on the daily chart around $140. It is currently in a p
Abbott and Amazon: Two Bright Spots in a Sea of Red◉ Abbott Laboratories NYSE:ABT
● The stock previously faced strong resistance near the $134 level, leading to an extended consolidation phase.
● During this period, a Rounding Bottom pattern emerged, signalling a potential continuation of the upward trend.
● Following a recent breakout, the stoc
ABT Bullish Momentum – Move Toward $141.60 ExpectedNYSE:ABT is showing strong bullish momentum, trading within an ascending channel and steadily approaching the upper boundary. The recent price action highlights consistent buying pressure, suggesting a potential continuation toward the $141.60 level.
The stock has maintained its position above key
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US2824BH2
ABBOTT LABS 16/46Yield to maturity
5.75%
Maturity date
Nov 30, 2046
ABT4466215
Abbott Laboratories 4.75% 15-APR-2043Yield to maturity
5.64%
Maturity date
Apr 15, 2043
ABT.HB
Abbott Laboratories 5.3% 27-MAY-2040Yield to maturity
5.28%
Maturity date
May 27, 2040
ABLC
ABBOTT LABS 16/36Yield to maturity
5.06%
Maturity date
Nov 30, 2036
ABT.GX
Abbott Laboratories 6.0% 01-APR-2039Yield to maturity
5.01%
Maturity date
Apr 1, 2039
ABT.GW
Abbott Laboratories 6.15% 30-NOV-2037Yield to maturity
5.00%
Maturity date
Nov 30, 2037
US2824BQ2
ABBOTT LAB 20/30Yield to maturity
4.60%
Maturity date
Jun 30, 2030
ABT4466374
Abbott Laboratories 3.875% 15-SEP-2025Yield to maturity
4.15%
Maturity date
Sep 15, 2025
US2824BF6
ABBOTT LABS 16/26Yield to maturity
4.12%
Maturity date
Nov 30, 2026
See all ABT bonds
Curated watchlists where ABT is featured.
